Thyroid FNA Cytology
portes grátis
Thyroid FNA Cytology
Differential Diagnoses and Pitfalls
Hirokawa, Mitsuyoshi; Bychkov, Andrey; Kakudo, Kennichi; Jung, Chan Kwon; Lai, Chiung-Ru; Liu, Zhiyan
Springer Verlag, Singapore
02/2024
837
Dura
Inglês
9789819967810
15 a 20 dias
Descrição não disponível.
I: Why Are There Significant Differences Among Us in Thyroid Nodule Practices?.- 1. Addressing the Impact of International Variation in Thyroid Cytology. Which Reporting System is best for Patients?.- 2. Diagnostic Criteria of Papillary Thyroid Carcinoma (PTC)-Type Nuclear Features Impacting Thyroid Fine Needle Aspiration (FNA) Cytology.- 3. Differences among thyroid FNA practices elucidated by meta-analyses of the literature.- 4. International Comparison Study of Thyroid Fine Needle Aspiration (FNA) Cytology Reporting System.- 5. Thyroid FNA terminology: Progress Towards a Single Unified International System for Thyroid FNA Reporting.- II: Reporting Systems of Thyroid FNA Cytology.- 6. Introduction to the third edition of the Bethesda System for Reporting Thyroid Cytopathology.- 7. The 2014 Italian Reporting System For Thyroid Cytology: Present and Future.- 8. The UK Royal College of Pathologists (RCPath) Thy Terminology for Reporting Thyroid FNA Cytology.- 9. Australian System forReporting Thyroid Cytology.- 10. The Japanese System Recommended by the Japan Thyroid Association.- 11. Risk Classification of Follicular Pattern Lesions in Thyroid FNA.- 12. Japanese Reporting System for Thyroid Aspiration Cytology (JRSTAC).- 13. Clinical Management for Follicular Neoplasm without Molecular Testing.- III: Classification of Thyroid Tumors.- 14. Histological Classification of Thyroid Tumors by the new 5th Edition WHO Classification.- 15. Low-risk Neoplasms in the 5th Edition of the WHO Classification of Thyroid Tumors.- 16. Clinically Insignificant Papillary Thyroid Carcinoma and Self-limiting Carcinoma that do not Harm Patients.- 17. Whole Tumor Capsule Is Prognostic Of Very Good Outcome In The Classical Variant Of Papillary Thyroid Cancer.- 18. A Framework For Approaching Cytologically Indeterminant Thyroid Nodules With Ras Mutations: A North American Perspective.- 19. Clinical Advantages and Limitations of Tumours Displaying Minimal and Extensive Vascular Invasion.-20. High-grade follicular cell-derived non-anaplastic thyroid carcinomas.- 21. Molecular classification of thyroid tumors and key molecular features to identify high-grade thyroid carcinomas.- IV: Criteria for Each Cytological Category.- 22. Specimen Adequacy and Non-diagnostic Thyroid Nodules.- 23. Cyst Fluid Only Samples.- 24. Cytology of benign thyroid aspirates.- 25. AUS/FLUS in the third edition Bethesda system.- 26. Cytological Diagnosis of FN Nodules.- 27. Diagnostic Criteria of Suspicious for Malignancy.- 28. Cytological Diagnoses of Malignancy and Nuclear Features of PTC.- V: Cytological Features of Thyroid Lesions.- 29. Diagnostic Clues for Thyroid Aspiration Cytology.- 30. False Positive in Thyroid FNA: Causes and How to Avoid Them.- 31. Papillae in thyroid aspirates.- 32. Papillary thyroid carcinoma on LBC preparation.- 33. Spindle cells in thyroid aspirates.- VI: Benign Lesions, Differential Diagnoses and Pitfalls.- 34. Thyroglossal Duct Cyst and Other Ectopic Thyroid Tissues in the Neck.- 35. Benign follicular pattern lesions (nodular hyperplasia).- 36. Infectious Thyroiditis.- 37. Diagnostic Considerations for Thyroid Nodules in Graves' Disease.- 38. Subacute Thyroiditis or Papillary Carcinoma.- 39. Hashimoto's Thyroiditis or Papillary Carcinoma.- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls.- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls.- 40. NIFTP in Asian practice.- 41. Role of FNA Cytology in Preoperative Prediction of NIFTP - Practical Experiences in North America.- 42. Hyalinizing Trabecular Tumor.- VIII: Papillary Thyroid Carcinoma, Differential Diagnoses and Pitfalls.- 43. Cystic Papillary Thyroid Carcinoma.- 44. Tall Cell Variant of Papillary Thyroid Carcinoma.- 45. Papillary carcinoma, Columnar Cell Variant---Diagnostic Pitfalls and Differential Diagnoses.- 46.Hobnail Papillary Thyroid Carcinoma.- 47. Solid/Trabecular Variant of Papillary Thyroid Carcinoma.- 48. Aggressive Subtypes of PTC, How to Handle themin FNA Cytology.- IX: High-Grade Carcinomas, Differential Diagnoses and Pitfalls.- 49. High-grade follicular-derived Carcinomas in FNA Cytology.- 50. Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid.- 51. Anaplastic Thyroid Carcinoma.- 52. Metastasis to Thyroid.- X: Other Thyroid Lesions, Differential Diagnoses and Pitfalls.- 53. Cribriform-Morular Thyroid Carcinoma.- 54. Oncocytic Cell Neoplasms in Hematoxylin-Eosin-Stained Samples.- 55. Huerthle Cell Neoplasms in Papanicolaou- and Romanowsky-Stained Specimens.- 56. Medullary (C Cell) Thyroid Carcinoma or Oxyphilic Follicular Neoplasms.- 57. Diagnosis of Medullary (C cell) Thyroid Carcinoma.- 58. Primary Thyroid Lymphoma.- 59. Rare Hematolymphoid Neoplasms of the Thyroid.- 60. Intrathyroid Thymic Carcinoma.- 61. Parathyroid Adenoma and Its Differential Diagnoses.- XI: How to Improve Diagnostic Performance in Thyroid FNA Cytology.- 62. How to Prepare Optimal FNA Samples.- 63. Staining Methods in Thyroid Cytology.-64. Fine Needle Aspiration Biopsy Complications.- 65. Liquid-Based Cytology Technique for Thyroid Cytology.- 66. Rapid on-site evaluation.- 67. Mobile rapid on-site evaluation.- 68. Low Cellularity Thyroid Fine Needle Aspiration Specimens: Differential Diagnosis, the Role of Ancillary Testing and Associated Diagnostic Challenges.- 69. The role of repeat FNA in indeterminate thyroid nodules.- 70. Frozen section and intraoperative imprint cytology.- 71. Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Pathologic Aspects.- 72. Biochemical Test of Fine-needle Aspirate as an Adjunct to Cytological Diagnosis in Patients with Thyroid Cancer or Primary Hyperparathyroidism.- 73. Quality Control for Cytology Laboratory in the USA.- 74. Infection control in cytology practice and the COVID19 pandemic.- XII: Immunohistochemistry in Thyroid Nodule Practice.- 75. Cell blocks in cytopathology and its role in evaluation of thyroid aspirates.- 76. European experience and recommendations on immunohistochemistry on cytology specimens.- 77. Application of Immunocytochemistry in Thyroid Aspiration Cytology.- XIII: Molecular Tests in Thyroid Nodule Practice.- 78. Practice of Molecular Detection of Thyroid Fine Needle Aspiration Specimen in China.- 79. Experience in Molecular Testing Using FNA Cytology in EU Countries.- 80. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada.- 81. Thyroid Fine Needle Aspiration Cytology Molecular Testing in the USA.- 82. Molecular Target Therapy for Pathologists in Advanced Thyroid Carcinoma.- XIV: Image Technology in Thyroid Nodule Practice.- 83. Pathologic Basis for Thyroid Ultrasound.- 84. Ultrasonography of the thyroid gland.- 85. Nuclear imaging of the thyroid gland.- XV: Clinical Guidelines in Thyroid Nodule Practice.- 86. International Comparison Study of Clinical Guidelines for Thyroid Nodule Evaluation.- 87. How to Follow FNA-confirmed Benign Thyroid Nodules.- 88. Management of PapillaryMicrocarcinoma of the Thyroid.- 89. Active surveillance of low-risk thyroid carcinoma in Western practice.- XVI: Thyroid Carcinoma in Children and Young Adults.- 90. Thyroid Nodules in Children and Adolescents.- 91. Thyroid Carcinoma of Young Adults and Children.- 92. The role of thyroid FNA cytology in pediatric malignant lesions: Case illustrations and literature review.- XVII: Patient Oriented Thyroid Nodule Practice.- 93. One Stop Clinic for Thyroid Nodules.- 94. Caring for Patients with Thyroid Nodules: Preventing Overdiagnosis as a Harm of FNA Cytological Examinations.- 95. Consideration of Patients' Viewpoint and the Role of Pathologists in Reporting Diagnosis of Thyroid Carcinomas.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Fine-needle aspiration;Cytopathology;WHO classification;Papillary thryoid carcinoma;AUS/FLUS;NIFTP;Thyroiditis;Borderline Tumor;Risk Stratification
I: Why Are There Significant Differences Among Us in Thyroid Nodule Practices?.- 1. Addressing the Impact of International Variation in Thyroid Cytology. Which Reporting System is best for Patients?.- 2. Diagnostic Criteria of Papillary Thyroid Carcinoma (PTC)-Type Nuclear Features Impacting Thyroid Fine Needle Aspiration (FNA) Cytology.- 3. Differences among thyroid FNA practices elucidated by meta-analyses of the literature.- 4. International Comparison Study of Thyroid Fine Needle Aspiration (FNA) Cytology Reporting System.- 5. Thyroid FNA terminology: Progress Towards a Single Unified International System for Thyroid FNA Reporting.- II: Reporting Systems of Thyroid FNA Cytology.- 6. Introduction to the third edition of the Bethesda System for Reporting Thyroid Cytopathology.- 7. The 2014 Italian Reporting System For Thyroid Cytology: Present and Future.- 8. The UK Royal College of Pathologists (RCPath) Thy Terminology for Reporting Thyroid FNA Cytology.- 9. Australian System forReporting Thyroid Cytology.- 10. The Japanese System Recommended by the Japan Thyroid Association.- 11. Risk Classification of Follicular Pattern Lesions in Thyroid FNA.- 12. Japanese Reporting System for Thyroid Aspiration Cytology (JRSTAC).- 13. Clinical Management for Follicular Neoplasm without Molecular Testing.- III: Classification of Thyroid Tumors.- 14. Histological Classification of Thyroid Tumors by the new 5th Edition WHO Classification.- 15. Low-risk Neoplasms in the 5th Edition of the WHO Classification of Thyroid Tumors.- 16. Clinically Insignificant Papillary Thyroid Carcinoma and Self-limiting Carcinoma that do not Harm Patients.- 17. Whole Tumor Capsule Is Prognostic Of Very Good Outcome In The Classical Variant Of Papillary Thyroid Cancer.- 18. A Framework For Approaching Cytologically Indeterminant Thyroid Nodules With Ras Mutations: A North American Perspective.- 19. Clinical Advantages and Limitations of Tumours Displaying Minimal and Extensive Vascular Invasion.-20. High-grade follicular cell-derived non-anaplastic thyroid carcinomas.- 21. Molecular classification of thyroid tumors and key molecular features to identify high-grade thyroid carcinomas.- IV: Criteria for Each Cytological Category.- 22. Specimen Adequacy and Non-diagnostic Thyroid Nodules.- 23. Cyst Fluid Only Samples.- 24. Cytology of benign thyroid aspirates.- 25. AUS/FLUS in the third edition Bethesda system.- 26. Cytological Diagnosis of FN Nodules.- 27. Diagnostic Criteria of Suspicious for Malignancy.- 28. Cytological Diagnoses of Malignancy and Nuclear Features of PTC.- V: Cytological Features of Thyroid Lesions.- 29. Diagnostic Clues for Thyroid Aspiration Cytology.- 30. False Positive in Thyroid FNA: Causes and How to Avoid Them.- 31. Papillae in thyroid aspirates.- 32. Papillary thyroid carcinoma on LBC preparation.- 33. Spindle cells in thyroid aspirates.- VI: Benign Lesions, Differential Diagnoses and Pitfalls.- 34. Thyroglossal Duct Cyst and Other Ectopic Thyroid Tissues in the Neck.- 35. Benign follicular pattern lesions (nodular hyperplasia).- 36. Infectious Thyroiditis.- 37. Diagnostic Considerations for Thyroid Nodules in Graves' Disease.- 38. Subacute Thyroiditis or Papillary Carcinoma.- 39. Hashimoto's Thyroiditis or Papillary Carcinoma.- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls.- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls.- 40. NIFTP in Asian practice.- 41. Role of FNA Cytology in Preoperative Prediction of NIFTP - Practical Experiences in North America.- 42. Hyalinizing Trabecular Tumor.- VIII: Papillary Thyroid Carcinoma, Differential Diagnoses and Pitfalls.- 43. Cystic Papillary Thyroid Carcinoma.- 44. Tall Cell Variant of Papillary Thyroid Carcinoma.- 45. Papillary carcinoma, Columnar Cell Variant---Diagnostic Pitfalls and Differential Diagnoses.- 46.Hobnail Papillary Thyroid Carcinoma.- 47. Solid/Trabecular Variant of Papillary Thyroid Carcinoma.- 48. Aggressive Subtypes of PTC, How to Handle themin FNA Cytology.- IX: High-Grade Carcinomas, Differential Diagnoses and Pitfalls.- 49. High-grade follicular-derived Carcinomas in FNA Cytology.- 50. Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid.- 51. Anaplastic Thyroid Carcinoma.- 52. Metastasis to Thyroid.- X: Other Thyroid Lesions, Differential Diagnoses and Pitfalls.- 53. Cribriform-Morular Thyroid Carcinoma.- 54. Oncocytic Cell Neoplasms in Hematoxylin-Eosin-Stained Samples.- 55. Huerthle Cell Neoplasms in Papanicolaou- and Romanowsky-Stained Specimens.- 56. Medullary (C Cell) Thyroid Carcinoma or Oxyphilic Follicular Neoplasms.- 57. Diagnosis of Medullary (C cell) Thyroid Carcinoma.- 58. Primary Thyroid Lymphoma.- 59. Rare Hematolymphoid Neoplasms of the Thyroid.- 60. Intrathyroid Thymic Carcinoma.- 61. Parathyroid Adenoma and Its Differential Diagnoses.- XI: How to Improve Diagnostic Performance in Thyroid FNA Cytology.- 62. How to Prepare Optimal FNA Samples.- 63. Staining Methods in Thyroid Cytology.-64. Fine Needle Aspiration Biopsy Complications.- 65. Liquid-Based Cytology Technique for Thyroid Cytology.- 66. Rapid on-site evaluation.- 67. Mobile rapid on-site evaluation.- 68. Low Cellularity Thyroid Fine Needle Aspiration Specimens: Differential Diagnosis, the Role of Ancillary Testing and Associated Diagnostic Challenges.- 69. The role of repeat FNA in indeterminate thyroid nodules.- 70. Frozen section and intraoperative imprint cytology.- 71. Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Pathologic Aspects.- 72. Biochemical Test of Fine-needle Aspirate as an Adjunct to Cytological Diagnosis in Patients with Thyroid Cancer or Primary Hyperparathyroidism.- 73. Quality Control for Cytology Laboratory in the USA.- 74. Infection control in cytology practice and the COVID19 pandemic.- XII: Immunohistochemistry in Thyroid Nodule Practice.- 75. Cell blocks in cytopathology and its role in evaluation of thyroid aspirates.- 76. European experience and recommendations on immunohistochemistry on cytology specimens.- 77. Application of Immunocytochemistry in Thyroid Aspiration Cytology.- XIII: Molecular Tests in Thyroid Nodule Practice.- 78. Practice of Molecular Detection of Thyroid Fine Needle Aspiration Specimen in China.- 79. Experience in Molecular Testing Using FNA Cytology in EU Countries.- 80. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada.- 81. Thyroid Fine Needle Aspiration Cytology Molecular Testing in the USA.- 82. Molecular Target Therapy for Pathologists in Advanced Thyroid Carcinoma.- XIV: Image Technology in Thyroid Nodule Practice.- 83. Pathologic Basis for Thyroid Ultrasound.- 84. Ultrasonography of the thyroid gland.- 85. Nuclear imaging of the thyroid gland.- XV: Clinical Guidelines in Thyroid Nodule Practice.- 86. International Comparison Study of Clinical Guidelines for Thyroid Nodule Evaluation.- 87. How to Follow FNA-confirmed Benign Thyroid Nodules.- 88. Management of PapillaryMicrocarcinoma of the Thyroid.- 89. Active surveillance of low-risk thyroid carcinoma in Western practice.- XVI: Thyroid Carcinoma in Children and Young Adults.- 90. Thyroid Nodules in Children and Adolescents.- 91. Thyroid Carcinoma of Young Adults and Children.- 92. The role of thyroid FNA cytology in pediatric malignant lesions: Case illustrations and literature review.- XVII: Patient Oriented Thyroid Nodule Practice.- 93. One Stop Clinic for Thyroid Nodules.- 94. Caring for Patients with Thyroid Nodules: Preventing Overdiagnosis as a Harm of FNA Cytological Examinations.- 95. Consideration of Patients' Viewpoint and the Role of Pathologists in Reporting Diagnosis of Thyroid Carcinomas.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
